119 A Novel Radiographic Signature of Immune Exclusion in Brain Metastases

View at publisher Summarise with VIRAT
Authors: Shivani Baisiwala, Francesco Sanvito, Andrea Liang, Jorge E. Salcedo-Sifuentes, William Delery, Cassia A. B. Maniquis, Ryan M. Shih, Yashaar Hafizka, Lu Sun, Ji Park, Alexander C. Boyarko, Alan Lee
+4 more Noriko Salamon, Robert Michael Prins, Jingwen Yao, Won Kim
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Brain metastases are the most common intracranial tumors, affecting nearly 25% of cancer patients. Immune exclusion is associated with poor response to immunotherapy. Identifying this phenomenon radiographically could provide a powerful, noninvasive biomarker to guide treatment selection and patient stratification. METHODS: We retrospectively reviewed 239 patients with brain metastases who subsequently underwent resection. Post-contrast T1-weighted MRIs were examined by three radiologists to identify cases with a hyper-enhancing peripheral rim. A set of qualitative imaging features (VASARI) was evaluated and compared between cases with no signature, inconsistent reading, and consensus agreement. in cases with consensus agreement, ADC values were compared between the peripheral rim and the tumor core. in a subset of 6 subjects with matched core tumor and peripheral enhancing region biopsies, CD45 immunofluorescence was performed for histological confirmation. RESULTS: Radiographic reads showed consensus on the presence of the hyper-enhancing rim in 8% of patients. In these cases, the rim showed elevated ADC values relative to the tumor core (1.47 vs 1.15 × 10-3 mm2/s; p < 0.001). These cases also showed significantly different VASARI features compared to cases without the radiographic signature, including more frequent deep white matter involvement (p < 0.001). Histology in a preliminary set of 6 subjects confirmed that these areas contained elevated CD45 expression, consistent with a pattern of immune exclusion. CONCLUSIONS: We report a novel radiographic phenotype in brain metastases, characterized by peripheral hyper-enhancement and elevated ADC signal. Preliminary histological analyses suggest that this phenotype may reflect areas of peripheral immunologic exclusion. With further validation, this imaging signature may hold promise as a noninvasive marker for immunologic tumor profiling, potentially informing patient stratification and therapeutic decision-making in the context of immunotherapy.

Fields of Study & Subjects

Brain Metastases and Treatment Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
16–16
Publication date
26 March 2026
Language
EN